This week’s episode is part 2 of 5 of a joint mini-series with our friends Two Onc Docs. In today’s episode, we recap the current treatment of classical hodgkin’s lymphoma and then dive into the the SWOG 1826 plenary session abstract from the ASCO 2023 annual meeting. We also cover the concept of “p-values” and what it means when trials say “the median was not reached.”

Content:

- A quick recap of the current standard of care for classical hodgkin's lymphoma

- A review of the recent SWOG 1826 trial presented at ASCO 2023

- A discussion about "p-values"

- A discussion about what it means when "the median was not reached"

Want to reach the abstract yourself? Click here: https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.17_suppl.LBA4?af=R

Have you checked out Episode 1? See link here for this episode released by Two Onc Docs: https://podcasts.apple.com/us/podcast/updates-from-asco23-rectal-cancer-the-prospect-trial/id1616541733?i=1000616604349

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Episode 061: “Paging Heme/Onc: Updates from ASCO 2023” - Classical Hodgkin’s Lymphoma and SWOG 1826

The Fellow on Call: The Heme/Onc Podcast

Episode 061: “Paging Heme/Onc: Updates from ASCO 2023” - Classical Hodgkin’s Lymphoma and SWOG 1826